chr15-33662351-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001036.6(RYR3):c.4821T>C(p.Tyr1607Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0027 in 1,612,820 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 11 hom. )
Consequence
RYR3
NM_001036.6 synonymous
NM_001036.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.771
Publications
1 publications found
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
- congenital myopathyInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 15-33662351-T-C is Benign according to our data. Variant chr15-33662351-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 461919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.771 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 11 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RYR3 | ENST00000634891.2 | c.4821T>C | p.Tyr1607Tyr | synonymous_variant | Exon 35 of 104 | 1 | NM_001036.6 | ENSP00000489262.1 | ||
| RYR3 | ENST00000389232.9 | c.4821T>C | p.Tyr1607Tyr | synonymous_variant | Exon 35 of 104 | 5 | ENSP00000373884.5 | |||
| RYR3 | ENST00000415757.7 | c.4821T>C | p.Tyr1607Tyr | synonymous_variant | Exon 35 of 103 | 2 | ENSP00000399610.3 | |||
| RYR3 | ENST00000634418.1 | c.4821T>C | p.Tyr1607Tyr | synonymous_variant | Exon 35 of 102 | 5 | ENSP00000489529.1 |
Frequencies
GnomAD3 genomes AF: 0.00171 AC: 261AN: 152254Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
261
AN:
152254
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00188 AC: 464AN: 246396 AF XY: 0.00196 show subpopulations
GnomAD2 exomes
AF:
AC:
464
AN:
246396
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00280 AC: 4091AN: 1460448Hom.: 11 Cov.: 31 AF XY: 0.00274 AC XY: 1991AN XY: 726362 show subpopulations
GnomAD4 exome
AF:
AC:
4091
AN:
1460448
Hom.:
Cov.:
31
AF XY:
AC XY:
1991
AN XY:
726362
show subpopulations
African (AFR)
AF:
AC:
17
AN:
33456
American (AMR)
AF:
AC:
73
AN:
44488
Ashkenazi Jewish (ASJ)
AF:
AC:
25
AN:
26078
East Asian (EAS)
AF:
AC:
0
AN:
39682
South Asian (SAS)
AF:
AC:
8
AN:
85848
European-Finnish (FIN)
AF:
AC:
34
AN:
53356
Middle Eastern (MID)
AF:
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
3800
AN:
1111434
Other (OTH)
AF:
AC:
130
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
249
498
748
997
1246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00171 AC: 261AN: 152372Hom.: 0 Cov.: 33 AF XY: 0.00149 AC XY: 111AN XY: 74512 show subpopulations
GnomAD4 genome
AF:
AC:
261
AN:
152372
Hom.:
Cov.:
33
AF XY:
AC XY:
111
AN XY:
74512
show subpopulations
African (AFR)
AF:
AC:
24
AN:
41592
American (AMR)
AF:
AC:
20
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
AC:
10
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
195
AN:
68042
Other (OTH)
AF:
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epileptic encephalopathy Benign:1
Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
RYR3: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.